You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 30 No. 1, January 1974 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Zinc, Taurine, and Epilepsy

André Barbeau, MD, FRCP(C); John Donaldson, PhD

Arch Neurol. 1974;30(1):52-58.


Abstract

Recent experiments from our laboratory and others demonstrate that sodium-potassium-adenosine triphosphatase inhibition, particularly in the hippocampus, is involved in epileptogenicity. Zinc ions can mimic ouabain when injected intraventricularly and can produce epileptic seizures in rats; serum zinc levels in treated epileptics are significantly decreased as compared to age- and sex-matched controls. Taurine, a nonessential amino acid, can decrease seizures in a variety of animal species and is particularly effective against our model of ouabain-induced seizures in rats. Preliminary experiments in human epileptic subjects confirm the anticonvulsive effect of taurine. These results justify controlled therapeutic trials of taurine and detailed biochemical studies of zinc metabolism in human epilepsy.



Author Affiliations

Montreal

From the Department of Neurobiology, Clinical Research Institute of Montreal.


Footnotes

Accepted for publication Aug 23, 1973.

Read in part before the Joint Meeting of the American Neurological Association and Canadian Congress of Neurological Sciences, Montreal, June 11, 1973.

Reprint requests to Clinical Research Institute of Montreal, 110 W Pine Ave, Montreal 130, Quebec, Canada (Dr. Barbeau).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Serum Zinc Levels in Children With Simple Febrile Seizure
Ganesh and Janakiraman
CLIN PEDIATR 2008;47:164-166.
ABSTRACT  

Oscillatory Potentials and Light Microscopic Changes Demonstrate an Interaction between Zinc and Taurine in the Developing Rat Retina
Gottschall-Pass et al.
J. Nutr. 1997;127:1206-1213.
ABSTRACT | FULL TEXT  

Low Erythrocyte Zinc Content in Acquired Aphasia With Convulsive Disorder (Landau-Kleffner Syndrome)
Lerman-Sagie et al.
J Child Neurol 1987;2:28-30.
ABSTRACT  

Hypercupraemia Induced by Antiepileptic Drugs
Ghose and Taylor
Hum Exp Toxicol 1983;2:519-529.
ABSTRACT  

Effects of Taurine on Seizures and Growth Hormone Release in Epileptic Patients
Mantovani and DeVivo
Arch Neurol 1979;36:672-674.
ABSTRACT  

Amino Acids in Human Epileptogenic Foci
Perry et al.
Arch Neurol 1975;32:752-754.
ABSTRACT  

Zinc Distribution in Mouse Brain Subsequent to Hippocampal Lesions
Berger and O'Leary
Arch Neurol 1975;32:295-297.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1974 American Medical Association. All Rights Reserved.